CD44 and glioblastoma: Localization of CD44 outside lipid rafts in human glioblastoma allows metalloproteinase-mediated CD44 shedding and tumor cell migration [107] while raft disruption by cyclodestrins or simvastatin increase CD44 shedding and migration.